Is MAIA Biotechnology Inc (AMEX: MAIA) Worth Your Money In 2025?

In today’s recent session, 1.99 million shares of the MAIA Biotechnology Inc (AMEX:MAIA) have been traded, and its beta is 0.05. Most recently the company’s share price was $1.87, and it changed around $0.21 or 12.66% from the last close, which brings the market valuation of the company to $56.68M. MAIA at last check was trading at a discount to its 52-week high of $4.24, offering almost -126.74% off that amount. The share price’s 52-week low was $1.40, which indicates that the recent value has risen by an impressive 25.13% since then. We note from MAIA Biotechnology Inc’s average daily trading volume that its 10-day average is 0.36 million shares, with the 3-month average coming to 242.61K.

MAIA Biotechnology Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended MAIA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

MAIA Biotechnology Inc (AMEX:MAIA) trade information

Instantly MAIA has been showing a green trend so far today with a performance of 12.66% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.9400 on recent trading dayincreased the stock’s daily price by 3.61%. The company’s shares are currently down -5.55% year-to-date, but still up 6.86% over the last five days. On the other hand, MAIA Biotechnology Inc (AMEX:MAIA) is 2.19% up in the 30-day period. We can see from the shorts that 0.36 million shares have been sold at a short interest cover period of 1.29 day(s).

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -11.40%.

MAIA Dividends

MAIA Biotechnology Inc’s next quarterly earnings report is expected to be released on 2025-May-09.

MAIA Biotechnology Inc (AMEX:MAIA)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 23.33% of MAIA Biotechnology Inc shares, and 4.88% of them are in the hands of institutional investors. The stock currently has a share float of 6.36%. MAIA Biotechnology Inc stock is held by 23.0 institutions, with HALTER FERGUSON FINANCIAL INC. being the largest institutional investor. By 2024-06-30, it held 4.1% of the shares, which is about 0.72 million shares worth $2.47 million.

VANGUARD GROUP INC, with 3.051% or 0.54 million shares worth $1.84 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.